Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Travoprost MeSH Descriptor Data 2025


MeSH Heading
Travoprost
Tree Number(s)
D10.251.355.255.550.775.500.175.500
D23.469.050.175.725.775.500.175.500
D23.469.700.670.175.500
Unique ID
D000069557
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069557
Scope Note
A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
Entry Term(s)
(((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
AL-6221
AL6221
Travatan
Travatan Z
Pharm Action
Antihypertensive Agents
Registry Numbers
WJ68R08KX9
0
Related Numbers
157283-68-6
Public MeSH Note
2016; TRAVOPROST was indexed under CLOPROSTENOL 2001-2015
History Note
2016 (2001)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2015/06/26
Travoprost Preferred
(((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester Narrower
AL-6221 Narrower
Travatan Narrower
Travatan Z Narrower
page delivered in 0.142s